Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. Profits ...

The Atlanta Braves are at the finish line of the 2025 season. While there are still a handful of games to play, much of the focus is starting to shift to the offseason. Let’s take a look at three ...

LOS ANGELES — The Cincinnati Reds’ season lasted three days longer than anyone expected, but the offseason began Wednesday night after losing Game 2 of the National League Wild Card Series. Though the ...

Ben Johnson’s Chicago Bears found their first victory of the season Sunday with a 31-14 win over the Dallas Cowboys. Quarterback Caleb Williams threw for 298 yards and four touchdowns, including a ...

CLEVELAND — There were times in June, July and August when it would have made sense to think about the upcoming Guardians offseason. As the club sputtered through lengthy losing streaks and suffered ...

Not exactly a new lesson but more of a reminder – Josh Allen can still do it himself. His 27-yard run in the fourth quarter gave the Bills a spark, and he threw a touchdown to tight end Dalton Kincaid ...

Mississippi State football is undefeated through four games, its best start since 2014. The Bulldogs face their first SEC opponent, Tennessee, after not winning a conference game last season. MSU's ...

PLYMOUTH MEETING, Pa., September 24, 2025--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the ...

The Detroit Tigers may have squeaked into the postseason, but they're hoping to roar once the wild-card games start. They do have a few issues to address, however. The Tigers are taking on the ...

For the majority of the summer, the news was really good for the Los Angeles Clippers. They restocked the team with two former All-Stars in Bradley Beal and Brook Lopez. The Clippers will host the All ...

Roche has reported a phase 3 win for its oral selective estrogen receptor degrader (SERD), bouncing back from an earlier setback to deliver data that could support filings for approval in breast ...

Join the chat as ESPN fantasy football expert Eric Moody will be here to answer all of your start/sit questions and other fantasy-related queries, live from noon to 1 p.m. ET every Sunday of the NFL's ...